Zai Lab Ltd (NASDAQ:ZLAB)
| 85.95 Delayed Data As of 3:59pm ET |  +0.27 / +0.32%Today’s Change | 29.43 Today|||52-Week Range 89.48 | +106.66% Year-to-Date |
Latest ZLAB News | Press Releases
| Turning Point Therapeutics Licenses Its Lung Cancer Drug in China Jul 07 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 85.68 |
| Today’s open | 86.26 |
| Day’s range | 84.51 - 86.86 |
| Volume | 11,223 |
| Average volume (3 months) | 437,334 |
| Market cap | $6.5B |
Data as of 3:59pm ET, 07/15/2020
Growth & Valuation
| Earnings growth (last year) | -14.94% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +9,957.04% |
| P/E ratio | NM |
| Price/Sales | 205.82 |
| Price/Book | 20.14 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVAXNovavax Inc | +1.10 | +1.00% |
| CRSPCRISPR Therapeutics ... | +2.42 | +2.66% |
| XLRNAcceleron Pharma Inc | +0.81 | +0.82% |
| ALLOAllogene Therapeutic... | +0.52 | +1.27% |
Data as of 4:54pm ET, 07/15/2020
Financials
| Next reporting date | August 27, 2020 |
| EPS forecast (this quarter) | -$1.03 |
| Annual revenue (last year) | $13.0M |
| Annual profit (last year) | -$195.4M |
| Net profit margin | -1,502.28% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Shanghai, Shanghai |
Forecasts
